CAndesartan vs LIsinopril Effects on the BRain

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 176 participants.

Also called NCT01984164

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose prevention
Phase
Phase 2
Enrolled
  • 176 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01984164
Other papers using this trial's data
  • Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults With Executive Mild Cognitive Impairment: A Randomized Clinical Trial JAMA network open, 2020-08-03 DOI, PubMed 32761160, PMC7411539 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01984164. Randomized; double masking; primary purpose prevention. Start 2014-08-20 (actual); primary completion 2018-12-03 (actual). Results posted on 2021-02-21.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
CAndesartan vs LIsinopril Effects on the BRain
Acronym
CALIBREX
Condition
Hypertension
Condition
Mild Cognitive Impairment
Intervention (Drug)
Candesartan
Intervention (Drug)
Lisinopril
Lead sponsor
Emory University (class: other)
Collaborator
National Institute on Aging (NIA) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct01984164
Content hash
f2a8fb27a4e36283eac28c6ee30e77c4b810b7e9e72d597ee296088ef03a7151